Madrigal Pharmaceuticals, Inc.
MDGL
Revenue
62.18M
▲47.54M▲324.75%
3 Months ChangeAssets
1.04B
▼-31.02M▼-2.89%
3 Months ChangeLiabilities
287.86M
▼-8.25M▼-2.78%
3 Months ChangeFree Cash Flow
-149.51M
▼-65.41M▼-77.78%
12 Months ChangeRevenue/Cost Of Revenue
Loading...
Net Profit/Loss
Loading...
Assets/Liabilities
Loading...
Cash Flows
Loading...
Loading...
Loading...
Recent Quarterly and Annual Filings
2024-10-31
Form 10-Q
ID: 0001628280-24-044445
2024-10-31
Form 8-K
ID: 0001193125-24-248137
2024-08-07
Form 10-Q
ID: 0001628280-24-035400
2024-08-07
Form 8-K
ID: 0001193125-24-195400
2024-06-27
Form 8-K
ID: 0001193125-24-170634
2024-05-07
Form 8-K
ID: 0001193125-24-133196
2024-05-07
Form 10-Q
ID: 0001628280-24-020865
2024-05-07
Form 8-K
ID: 0001193125-24-132559
2024-04-02
Form 8-K
ID: 0001193125-24-084797
2024-03-20
Form 8-K
ID: 0001193125-24-072706